Smith & Nephew plc (FRA:NPW1)

Market Cap	11.95B +17.8%
Revenue (ttm)	5.25B +6.1%
Net Income	532.31M +51.7%
EPS	0.61 +52.3%
Shares Out	n/a
PE Ratio	22.46
Forward PE	14.73
Dividend	0.34 (2.38%)
Ex-Dividend Date	Mar 26, 2026

Volume	n/a
Average Volume	1
Open	13.90
Previous Close	14.20
Day's Range	13.90 - 13.90
52-Week Range	11.58 - 16.64
Beta	n/a
RSI	43.40
Earnings Date	Apr 30, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 16,988
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NPW1

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Financial numbers in USD